age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
37.70798
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 41
| 28,257.281
| 19,791.9219
| null | 13
|
black
| 27.597656
| 44
| 0.736938
| 0.654907
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 123
| 2.399902
| 120
| 22
| 39.19531
| 485.6875
| 1.399902
| 3.799805
| 0.899902
| 145
| 7.489258
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 95
| 1
|
51.80798
|
male
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 85,036.875
| 57,495.9688
| null | 29.25
|
white
| 36.695313
| 54
| 0.62793
| 0.524902
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 23
| 69
| 18.898438
| 110
| 10
| 36.29688
| 90
| 2.299805
| 7.299805
| 1.299805
| 150
| 7.5
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 224
| 1
|
34.905
|
female
| 0
| 32
|
Lung Cancer
|
Cancer
| 1
| 15
|
$11-$25k
| 0
| 30,184.844
| 22,470.3438
| null | 10.5
|
black
| 12.898438
| 10
| 0.830933
| 0.631958
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.2
|
no dnr
| 32
| 83
| 1.099854
| 80
| 16
| 36.79688
| null | null | 0.399963
| 1.099854
| 142
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 426
| 1
|
67.16797
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 19
|
$25-$50k
| 0
| 2,869.35
| 2,204.5879
| null | 12
|
white
| 13.199219
| 15
| 0.858887
| 0.685913
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 5
| 105
| 5.399414
| 72
| 20
| 36.59375
| null | null | 0.299988
| 1
| 142
| null | null | null | null | 0
| 0
| null | 0
| 239
| 1
|
75.53198
|
female
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
| null | 89
| 65,764.688
| 46,593.75
| null | 30
|
black
| 48.09375
| 75
| 0
| 0
| 5
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 13
| 43
| 9.599609
| 0
| 25
| 35.59375
| 294
| null | 1.299805
| 3.399902
| 149
| 7.359375
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 26
| 1
|
59.53699
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 100
| 36,440.969
| 26,306.7969
| null | 48
|
white
| 76
| 97
| 0
| 0
| 3
| 1
| 0
|
no
| null | null |
dnr after sadm
| 3
| 0
| 26.296875
| 0
| 25
| 36.79688
| 151
| 3.199707
| 0.399963
| 10.099609
| 131
| 7.239258
| null | null | null | null | null |
<2 mo. follow-up
| 2.06543
| 3
| 1
|
52.49799
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 100
| 64,625.125
| 37,736.7812
| null | 60
|
white
| 73
| 101
| 0
| 0
| 18
| 1
| 0
|
no
| 0
| 0
|
no dnr
| 3
| 32
| 60.09375
| 0
| 12
| 38.09375
| 58
| null | 17.199219
| 4.699219
| 128
| 7.179688
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 3
| 1
|
33.49799
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 10
|
under $11k
| 0
| 38,352.75
| 26,380.8906
| null | 28
|
black
| 41.5
| 38
| 0.61792
| 0.512939
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 17
| 46
| 10.199219
| 114
| 34
| 34.89844
| 138.3125
| 3.299805
| 0.799927
| 0.5
| 138
| 7.339844
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,650
| 0
|
63.31299
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 6,546.547
| 4,539.9961
| null | 10.5
|
white
| 17
| 13
| 0.819946
| 0.610962
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 7
| 125
| 7.699219
| 100
| 20
| 36.19531
| null | null | 0.299988
| 0.799927
| 139
| null | null | null | null | null | null | null | 2.276367
| 1,023
| 1
|
71.09698
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 5
|
$11-$25k
| 0
| 6,796.148
| 4,837.2031
| null | 15.5
|
white
| 37.09375
| 29
| 0.33197
| 0.064987
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 8
| 90
| 13.298828
| 100
| 20
| 38
| null | 1.799805
| 2.399902
| 1
| 135
| null | null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 67
| 1
|
33.336
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
$11-$25k
| 0
| 38,332.438
| 27,009.375
| null | 21
|
white
| 23.796875
| 48
| 0.883911
| 0.842896
| 2
| 0
| 0
|
no
| null | null |
no dnr
| 16
| 145
| 21.199219
| 124
| 25
| 35.89844
| 300
| 1
| 0.199982
| 0.899902
| 135
| 7.509766
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,648
| 0
|
68.323
|
male
| 1
| 9
|
Coma
|
Coma
| 1
| 11
|
$25-$50k
| 89
| 40,760.781
| 27,743.625
| null | 30.5
|
white
| 20.199219
| 38
| 0.205994
| 0.144989
| 3
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 6
| 115
| 3.899902
| 110
| 40
| 38.29688
| 276.625
| 2.5
| 2
| 1.399902
| 139
| 7.519531
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
70.06195
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 0
| 60,256.219
| 41,535.4375
| null | 42.5
|
black
| 22.097656
| 32
| 0.776978
| 0.704956
| 6
| 1
| 0
|
no
| 0
| 0
|
no dnr
| 10
| 105
| 7.299805
| 126
| 32
| 36.09375
| 223.3125
| null | 1.099854
| 1.199951
| 142
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.163086
| 10
| 1
|
30.56499
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 41
| 111,994.75
| 75,745.25
| null | 48
|
black
| 34.09375
| 53
| 0.554932
| 0.441956
| 9
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 14
| 101
| 17.199219
| 114
| 9
| 35.29688
| 253.3125
| 1.099854
| 5.299805
| 4.199219
| 137
| 7.439453
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
55.047
|
male
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
|
$25-$50k
| 0
| 57,010.281
| 37,786.875
| null | 36
|
white
| 28.597656
| 41
| 0.773926
| 0.700928
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 17
| 62
| 10.5
| 136
| 22
| 37.89844
| 140.8125
| null | null | 2
| 142
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,648
| 0
|
64.51495
|
male
| 0
| 43
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
| null | 0
| 134,926.125
| 87,521.75
| null | 12.5
|
white
| 21.898438
| 29
| 0.80896
| 0.745972
| 4
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 43
| 62
| 11.199219
| 108
| 30
| 38.89844
| 196.65625
| null | null | 1
| 137
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,647
| 0
|
72.55896
|
male
| 1
| 26
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 0
| 117,551.375
| 78,834
| null | 50.5
|
white
| 49.09375
| 62
| 0.018997
| 0.004
| 2
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 5
| 43
| 1.399902
| 46
| 30
| 38.5
| 132.625
| 2.799805
| 1.599854
| 3.399902
| 145
| 7.399414
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
53.771
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 0
| 144,017.875
| 95,878.5
| null | 43.75
|
black
| 33.09375
| 47
| 0.650879
| 0.55188
| 4
| 0
| 0
|
no
| 0.2
| 0.1
|
dnr after sadm
| 28
| 65
| 21.597656
| 136
| 40
| 39.69531
| 127.5
| 1.099854
| null | 0.5
| 135
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
36.78
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 69,588.438
| 47,347.7812
| null | 20.75
|
white
| 23.398438
| 42
| 0.879883
| 0.837891
| 2
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 34
| 110
| 27.097656
| 64
| 29
| 36.79688
| 196.65625
| 2.5
| 2.199707
| 1.599854
| 143
| 7.449219
| null | null | null | 6
| 6
|
adl>=4 (>=5 if sur)
| 6
| 1,645
| 0
|
57.37198
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 6,919.348
| 4,499.9922
| null | 27
|
black
| 25.199219
| 40
| 0.824951
| 0.714966
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 5
| 57
| 11.298828
| 74
| 12
| 36
| null | null | null | 1.799805
| 131
| null | null | null | null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 1,644
| 0
|
66.06696
|
male
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
|
under $11k
| 0
| 8,746.344
| 6,254.4844
| null | 8.5
|
white
| 22.199219
| 23
| 0.834961
| 0.72998
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 11
| 101
| 12.5
| 120
| 24
| 36.19531
| 314.8125
| null | null | 1.399902
| 138
| 7.379883
| null | null | null | 5
| 6
|
adl>=4 (>=5 if sur)
| 6
| 108
| 1
|
44.71198
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 34,335.719
| 23,017.6406
| null | 40.5
|
black
| 24.699219
| 48
| 0.580933
| 0.471985
| 6
| 1
| 0
|
metastatic
| 0.05
| 0.000125
|
dnr after sadm
| 8
| 82
| 30.398438
| 136
| 37
| 38.09375
| 193.3125
| 1.799805
| 0.399963
| 0.899902
| 148
| 7.509766
| null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 8
| 1
|
66.53296
|
male
| 0
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 9
| null | 26
| 84,241.938
| 57,762.9375
| null | 20.75
|
black
| 17.5
| 11
| 0.806885
| 0.741943
| 3
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 53
| 113
| 7.399414
| 64
| 22
| 35.29688
| 390.4375
| null | null | 1
| 139
| 7.389648
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 941
| 1
|
64.47095
|
female
| 1
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$11-$25k
| 61
| 239,038.625
| 153,327.625
| null | 46.25
|
white
| 42.5
| 82
| 0.035995
| 0.009998
| 38
| 0
| 0
|
no
| null | null |
dnr after sadm
| 19
| 79
| 25.699219
| 150
| 14
| 38.5
| 274.25
| 3.699707
| 46
| 2.299805
| 156
| 7.509766
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 27
| 1
|
86.771
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 6
|
$25-$50k
| 0
| 9,572.992
| 6,706.3945
| null | 12
|
white
| 16.398438
| 24
| 0.793945
| 0.668945
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 1
| 77
| 5.399414
| 96
| 24
| 36.29688
| 254.15625
| null | 0.699951
| 0.899902
| 144
| 7.319336
| null | null | null | 1
| 1
|
no(M2 and SIP pres)
| 1
| 92
| 1
|
65.84497
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 36,142.5
| 23,028.0938
| null | 36
|
white
| 30.796875
| 45
| 0.694946
| 0.529907
| 1
| 1
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 11
| 56
| 7.5
| 96
| 26
| 34.89844
| 173.3125
| null | null | 0.699951
| 130
| 7.509766
| null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 21
| 1
|
36.46298
|
female
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 9
|
under $11k
| 44
| 43,674.094
| 27,369.0312
| null | 40.5
|
black
| 36.09375
| 49
| 0.539917
| 0.425964
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 7
| 49
| 6.699219
| 130
| 10
| 36.89844
| 380
| null | 3.799805
| 3.299805
| 143
| 7.419922
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
66.01196
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 10
|
under $11k
| 0
| 4,544.449
| 3,349.0293
| null | 13
|
white
| 17.097656
| 29
| 0.885986
| 0.809937
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 73
| 7.599609
| 80
| 20
| 36
| 232
| null | null | 1.599854
| 142
| 7.40918
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 809
| 1
|
57.34399
|
male
| 0
| 14
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 8
|
$11-$25k
| 0
| 16,616.234
| 11,228.8359
| null | 13
|
white
| 18.398438
| 26
| 0.894897
| 0.824951
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 14
| 73
| 8
| 114
| 16
| 35.29688
| 361.875
| 4
| 0.5
| 1.299805
| 142
| 7.469727
| null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 120
| 1
|
64.30096
|
male
| 0
| 4
|
Colon Cancer
|
Cancer
| 1
| 8
|
$25-$50k
| 0
| 2,797.75
| 1,885.8486
| null | 14
|
white
| 26.097656
| 14
| 0.656982
| 0.352966
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.25
|
no dnr
| 4
| 103
| 10
| 100
| 20
| 36.59375
| null | 2.899902
| 1.099854
| 0.599976
| 135
| null | null | null | null | 0
| 0
|
SIP>=30
| 0
| 107
| 1
|
74.836
|
male
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
| null | 9
| 100,695.688
| 62,287.8438
| null | 50.333313
|
white
| 33.796875
| 69
| 0.472961
| 0.35498
| 3
| 1
| 0
|
no
| null | null |
no dnr
| 20
| 114
| 11.599609
| 154
| 51
| 38
| 176.65625
| 3
| 0.099991
| 5.099609
| 148
| 7.429688
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 20
| 1
|
44.45697
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 64,678.375
| 43,669.75
| null | 35.333313
|
white
| 27.699219
| 34
| 0.822998
| 0.762939
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 23
| 71
| 13.199219
| 120
| 40
| 39
| 169.375
| null | 0.5
| 1.199951
| 152
| 7.369141
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,124
| 1
|
65.17694
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 0
| 75,953.688
| 54,295.0625
| null | 45
|
white
| 39.796875
| 68
| 0.146973
| 0.069992
| 57
| 1
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 2
| 52
| 0.099991
| 146
| 23
| 39
| 126.65625
| 2.399902
| 1.099854
| 0.799927
| 139
| 7.389648
| null | null | null | null | null |
<2 mo. follow-up
| 2.153809
| 5
| 1
|
40.961
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 37
| 26,437.453
| 17,019.7812
| null | 36
|
white
| 25.296875
| 49
| 0.726929
| 0.642944
| 6
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 4
| 60
| 6.5
| 134
| 42
| 38.5
| 200
| null | 0.299988
| 1.799805
| 143
| 7.389648
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 6
| 1
|
46.20099
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
| null | 0
| 48,938.625
| 31,128.8594
| null | 32
|
white
| 26.597656
| 23
| 0.831909
| 0.774902
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 16
| 47
| 7.699219
| 114
| 8
| 38.09375
| 205
| 2.699707
| 1.599854
| 0.799927
| 142
| 7.339844
| null | null | null | null | 5
|
adl>=4 (>=5 if sur)
| 5
| 494
| 1
|
46.80099
|
female
| 0
| 24
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 100,731.312
| 67,725
| null | 19.666656
|
white
| 25.398438
| 39
| 0.583984
| 0.474976
| 45
| 0
| 0
|
yes
| 0.2
| 0.1
|
no dnr
| 24
| 70
| 0.299988
| 80
| 24
| 36.09375
| 215
| 2.299805
| 1.399902
| 0.799927
| 138
| 7.429688
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 81
| 1
|
71.78894
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 14,408.992
| 9,772.8594
| null | 13.5
|
white
| 18.199219
| 29
| 0.861938
| 0.770996
| 1
| 1
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 13
| 82
| 5.799805
| 76
| 20
| 35.79688
| 304.75
| null | 0.399963
| 1.799805
| 144
| 7.389648
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 540
| 1
|
33.98798
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 32,652.094
| 21,513.1094
| null | 12
|
white
| 13.599609
| 12
| 0.941895
| 0.919922
| 4
| 0
| 0
|
no
| 0.98
| 0.97
|
no dnr
| 11
| 107
| 8.798828
| 78
| 24
| 36.69531
| 348.9375
| null | null | 1.199951
| 137
| 7.40918
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,627
| 0
|
34.44498
|
male
| 0
| 55
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 90,605.125
| 61,912.2812
| null | 25
|
black
| 33
| 80
| 0.781982
| 0.711914
| 1
| 0
| 0
|
no
| 0.1
| 0.001
|
no dnr
| 55
| 59
| 28.5
| 70
| 19
| 35.29688
| 323.75
| 1.799805
| 8.599609
| 2.399902
| 153
| 7.469727
| null | null | null | null | 0
| null | 0
| 1,627
| 0
|
62.37598
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 26,869.891
| 15,855.4297
| null | 49.5
|
black
| 46.296875
| 55
| 0.286987
| 0.176971
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
no dnr
| 7
| 42
| 13.5
| 116
| 14
| 35.5
| 173.46875
| 2.299805
| null | 2.599609
| 129
| 7.329102
| null | null | null | null | null |
<2 mo. follow-up
| 2.303711
| 7
| 1
|
72.73895
|
male
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 6
|
$11-$25k
| 0
| 237,319.75
| 164,784.5
| null | 9.333328
|
white
| 22.097656
| 32
| 0.712891
| 0.554932
| 105
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 14
| 57
| 7.399414
| 116
| 24
| 36.19531
| 259.25
| null | null | 0.899902
| 135
| 7.349609
| null | null | null | 0
| 0
|
SIP>=30
| 0
| 103
| 1
|
62.60397
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| 16
|
$11-$25k
| 0
| 6,939.148
| 4,463.418
| null | 8.5
|
white
| 11.699219
| 11
| 0.879883
| 0.727905
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 8
| 113
| 4.299805
| 66
| 16
| 37.69531
| null | 3.599609
| 0.599976
| 1.099854
| 139
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 785
| 1
|
73.05695
|
male
| 0
| 13
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| 26,677.734
| 17,147.4219
| null | 24.5
|
white
| 28.898438
| 42
| 0.490967
| 0.372986
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 13
| 69
| 20.296875
| 134
| 36
| 38
| 128.5625
| null | null | 1.299805
| 142
| 7.5
| null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 127
| 1
|
33.30899
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 1,949.499
| 1,513.6387
| null | 6
|
white
| 25.199219
| 34
| 0.893921
| 0.821899
| 1
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 3
| 93
| 14.298828
| 102
| 18
| 36.5
| 319
| null | null | 5.5
| 135
| 7.359375
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.129395
| 1,625
| 0
|
39.392
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 7
|
under $11k
| 37
| 25,431.641
| 16,257.5078
| null | 24.5
|
black
| 23.097656
| 45
| 0.813965
| 0.751953
| 1
| 0
| 0
|
no
| 0.25
| 0.2
|
dnr after sadm
| 12
| 59
| 35.296875
| 100
| 32
| 36.39844
| 428
| 2
| 2
| 1.099854
| 133
| 7.439453
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 13
| 1
|
50.297
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 17
|
$25-$50k
| 0
| 37,236.906
| 23,530.2969
| null | 20.333328
|
white
| 15.898438
| 25
| 0.925903
| 0.873901
| 1
| 1
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 16
| 79
| 6
| 76
| 28
| 36.29688
| 342.8125
| null | 1.199951
| 1.099854
| 138
| 7.459961
| null | null | null | null | 2
|
<2 mo. follow-up
| 2
| 55
| 1
|
62.64798
|
female
| 1
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 37
| 114,017.812
| 77,522.1875
| null | 42.666657
|
white
| 38.695313
| 39
| 0.058998
| 0.019997
| 23
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 15
| 113
| 13.798828
| 136
| 33
| 36.19531
| 55
| null | null | 0.699951
| 130
| 7.419922
| null | null | null | null | 1
|
<2 mo. follow-up
| 1
| 19
| 1
|
46.431
|
male
| 0
| 6
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 18
|
>$50k
| 0
| 13,625.547
| 10,169
| null | 11
|
white
| 22
| 32
| 0.832886
| 0.726929
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 109
| 7.599609
| 92
| 20
| 38.19531
| 154
| 2.199707
| 5.199219
| 0.799927
| 141
| 7.469727
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,625
| 0
|
44.48199
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 26
| 14,491.094
| 9,780.6641
| null | 20
|
white
| 49.398438
| 65
| 0.025997
| 0.006
| 1
| 1
| 0
|
yes
| 0
| 0
|
dnr after sadm
| 3
| 46
| 1.099854
| 130
| 12
| 36.29688
| 165.28125
| 1.699951
| null | 1.5
| 125
| 7.369141
| null | null | null | null | 4
|
<2 mo. follow-up
| 4
| 9
| 1
|
38.22598
|
female
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 26
| 113,644.312
| 77,640.1875
| null | 34.666657
|
black
| 24
| 37
| 0.762939
| 0.68689
| 37
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 6
| 53
| 9.5
| 166
| 20
| 38.59375
| 222.84375
| null | 0.799927
| 1.199951
| 147
| 7.399414
| null | null | null | null | null |
<2 mo. follow-up
| 2.05957
| 17
| 1
|
43.46899
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 9,109.25
| 5,954.8867
| null | 6
|
white
| 17.5
| 20
| 0.92688
| 0.875977
| 1
| 1
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 6
| 79
| 7
| 60
| 16
| 36
| null | null | 1.599854
| 1.199951
| 142
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,623
| 0
|
53.448
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 10
|
$25-$50k
| 0
| 8,706.695
| 5,779.0469
| null | 12
|
white
| 18
| 17
| 0.906982
| 0.842896
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 81
| 10.5
| 76
| 20
| 36.19531
| null | null | 0.599976
| 1.799805
| 140
| null | null | null | null | null | null | null | 1.733887
| 1,623
| 0
|
53.86697
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 3
|
under $11k
| 0
| 4,178.297
| 2,940.7246
| null | 6
|
black
| 19.097656
| 24
| 0.691895
| 0.401978
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.4
|
no dnr
| 6
| 70
| 42.398438
| 106
| 20
| 36.29688
| null | 3.799805
| 0.699951
| 1.399902
| 141
| null | null | null | null | null | 7
|
SIP>=30
| 7
| 71
| 1
|
63.51797
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 7
|
$25-$50k
| 0
| 12,290.547
| 9,199.0156
| null | 20.5
|
black
| 26.199219
| 46
| 0.787964
| 0.660889
| 1
| 1
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 7
| 122
| 11.298828
| 70
| 15
| 36.59375
| 156.65625
| null | null | 3.099609
| 136
| 7.369141
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,621
| 0
|
43.50699
|
male
| 0
| 23
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 35,417.5
| 23,980.9844
| null | 18
|
white
| 24
| 26
| 0.908936
| 0.846924
| 1
| 0
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 23
| 71
| 13.298828
| 66
| 14
| 35.39844
| 160
| null | null | 0.899902
| 134
| 7.439453
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 530
| 1
|
49.79898
|
male
| 1
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 9
| 44,865.125
| 29,697.0312
| null | 33
|
hispanic
| 34.898438
| 56
| 0.279968
| 0.17099
| 18
| 0
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 6
| 66
| 0.099991
| 120
| 12
| 36
| 177.5
| 1.399902
| 1.199951
| 0.799927
| 136
| 7.319336
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
64.12897
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 13
| null | 0
| 4,552
| 3,259.5019
| null | 9
|
white
| 14.298828
| 11
| 0.850952
| 0.670898
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 6
| 80
| 8.599609
| 60
| 16
| 37.5
| null | null | null | 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 344
| 1
|
40.88397
|
female
| 0
| 35
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 164,417.875
| 116,632.562
| null | 32.25
|
white
| 33.296875
| 71
| 0.678955
| 0.508911
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 35
| 59
| 12
| 118
| 41
| 38.69531
| 165
| 0.399963
| 14.398438
| 1
| 147
| 7.519531
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,619
| 0
|
65.92999
|
female
| 0
| 14
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 31,304.594
| 21,216.1562
| null | 19.666656
|
white
| 17.796875
| 19
| 0.881958
| 0.803955
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 14
| 105
| 9.099609
| 60
| 8
| 37.59375
| 216.65625
| null | 2.699707
| 0.699951
| 141
| 7.429688
| null | null | null | null | 0
| null | 0
| 867
| 1
|
63.88498
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 70,330.438
| 44,525.8125
| null | 56
|
white
| 60.898438
| 101
| 0
| 0
| 19
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 3
| 42
| 0.299988
| 210
| 40
| 40.09375
| 57
| 3.199707
| 3.599609
| 1.699951
| 154
| 7.389648
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 6
| 1
|
70.51599
|
male
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 72,465.938
| 44,700.5
| null | 55
|
white
| 36.398438
| 54
| 0.158997
| 0.077988
| 24
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 61
| 18.398438
| 166
| 16
| 39
| 70
| 2.899902
| 5.699219
| 1.399902
| 136
| 7.339844
| null | null | null | null | null |
<2 mo. follow-up
| 2.52002
| 8
| 1
|
59.69299
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 7
| null | 0
| 6,527.398
| 4,549.4727
| null | 13
|
white
| 23.199219
| 24
| 0.841919
| 0.740967
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 8
| 65
| 12.599609
| 94
| 20
| 35.09375
| 348
| null | 1.699951
| 1.699951
| 141
| 7.449219
| null | null | null | 3
| 3
|
<2 mo. follow-up
| 3
| 55
| 1
|
51.01398
|
female
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 14
| null | 0
| 26,606.234
| 19,481.5
| null | 18.666656
|
white
| 25.699219
| 27
| 0.661987
| 0.563965
| 2
| 0
| 0
|
yes
| null | null |
no dnr
| 18
| 64
| 9.898438
| 110
| 16
| 35.89844
| 236
| null | null | 1
| 126
| 7.55957
| null | null | null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 1,124
| 1
|
39.98898
|
male
| 0
| 47
|
Coma
|
Coma
| 0
| 11
|
$11-$25k
| 44
| 96,140.5
| 65,851.3125
| null | 27
|
black
| 22.199219
| 28
| 0.740967
| 0.692993
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 47
| 150
| 21.5
| 54
| 16
| 36.5
| 314.25
| null | 0.799927
| 2
| 142
| 7.549805
| null | null | null | null | 0
| null | 0
| 1,616
| 0
|
77.36896
|
male
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 16
|
$11-$25k
| 0
| 82,882
| 50,108.625
| null | 50
|
white
| 35.59375
| 64
| 0.181
| 0.093994
| 13
| 1
| 0
|
metastatic
| 0
| 0
|
no dnr
| 6
| 56
| 27.796875
| 144
| 15
| 36.39844
| 95
| 3
| 0.599976
| 1.899902
| 137
| 7.329102
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
49.28699
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 6,130.148
| 3,425.2812
| null | 9
|
white
| 28.097656
| 14
| 0.480957
| 0.162994
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 3
| 93
| 50
| 92
| 18
| 36.89844
| null | 2.599609
| 0.299988
| 0.899902
| 137
| null | null | null | null | 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 93
| 1
|
42.38199
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 61
| 17,956.734
| 11,401.1875
| null | 17
|
white
| 23.796875
| 9
| 0.720947
| 0.635986
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 13
| 100
| 10.398438
| 104
| 22
| 39.09375
| 165.28125
| null | null | 0.599976
| 145
| 7.40918
| null | null | null | null | 7
| null | 7
| 161
| 1
|
72.82996
|
male
| 1
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 26
|
$25-$50k
| 26
| 64,584.969
| 42,675.625
| null | 16.5
|
white
| 19.699219
| 24
| 0.653931
| 0.554932
| 9
| 0
| 0
|
yes
| 0.7
| 0.5
|
no dnr
| 28
| 123
| 25.597656
| 100
| 26
| 38.09375
| 220
| null | null | 0.799927
| 136
| 7.479492
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 28
| 1
|
38.63397
|
male
| 0
| 40
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 64,797.125
| 45,844.5625
| null | 13.75
|
white
| 26.796875
| 52
| 0.851929
| 0.799927
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 40
| 148
| 10.298828
| 64
| 35
| 36
| 280.9375
| 2.699707
| 0.199982
| 8.199219
| 129
| 7.379883
| null | null | null | 5
| 6
|
SIP>=30
| 6
| 280
| 1
|
57.33099
|
female
| 0
| 9
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$25-$50k
| 0
| 7,634.297
| 5,276.5508
| null | 14
|
white
| 20.199219
| 25
| 0.80188
| 0.680908
| 1
| 0
| 0
|
no
| null | 0.6
|
no dnr
| 9
| 77
| 5.5
| 80
| 22
| 36.5
| null | 3.299805
| 4
| 1.199951
| 128
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 24
| 1
|
71.51495
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| null | null | 61
| 79,534.062
| 50,686.5625
| null | 28.5
|
black
| 24.296875
| 42
| 0.237976
| 0.172974
| 8
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 60
| 12.699219
| 114
| 12
| 39.5
| 208.5625
| null | null | 9.798828
| 140
| 7.449219
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
70.30798
|
male
| 1
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 17
|
>$50k
| 9
| 65,747
| 42,281.875
| null | 39.666657
|
white
| 29.597656
| 54
| 0.488953
| 0.370972
| 2
| 0
| 0
|
yes
| null | null |
no dnr
| 16
| 56
| 9.699219
| 130
| 29
| 37.89844
| 226.65625
| 2.599609
| 1.299805
| 3.699707
| 137
| 7.489258
| null | null | null | null | 3
|
<2 mo. follow-up
| 3
| 16
| 1
|
51.258
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 11
|
>$50k
| 0
| 6,629.898
| 3,985.4883
| null | 18
|
white
| 15.5
| 15
| 0.85791
| 0.68396
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 150
| 6.399414
| 68
| 20
| 36.5
| null | null | 0.599976
| 0.699951
| 137
| null | null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 659
| 1
|
40.75
|
male
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 26
| 56,770.312
| 38,207.1875
| null | 28.25
|
white
| 22.5
| 35
| 0.841919
| 0.787964
| 1
| 0
| 0
|
no
| 0.95
| 0.94
|
no dnr
| 29
| 77
| 13.798828
| 124
| 38
| 38.19531
| 233.3125
| 2.099609
| 0.5
| 0.599976
| 137
| 7.479492
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,610
| 0
|
71.03595
|
female
| 1
| 50
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 101,556.688
| 70,590.1875
| null | 7.75
|
white
| 17.898438
| 21
| 0.812988
| 0.697998
| 14
| 0
| 0
|
no
| 0.75
| 0.6
|
dnr after sadm
| 46
| 73
| 9.099609
| 70
| 28
| 36.19531
| 736.625
| null | null | 0.699951
| 137
| 7.40918
| null | null | null | 2
| 0
|
<2 mo. follow-up
| 0
| 50
| 1
|
68.01898
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 7
| null | 0
| 3,755.648
| 2,598.2031
| null | 17
|
white
| 16.597656
| 21
| 0.816895
| 0.605957
| 1
| 0
| 0
|
metastatic
| 1
| 0.8
|
no dnr
| 5
| 107
| 7
| 76
| 24
| 36.19531
| null | null | 0.399963
| 1.699951
| 137
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 165
| 1
|
67.11298
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
|
under $11k
| 0
| 73,551.25
| 47,569.375
| null | 30.25
|
black
| 28
| 39
| 0.733887
| 0.650879
| 1
| 1
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 33
| 67
| 19.699219
| 114
| 8
| 39.09375
| 195
| null | 1.5
| 2.099609
| 132
| 7.509766
| null | null | null | null | 1
|
adl>=4 (>=5 if sur)
| 1
| 1,564
| 1
|
53.04898
|
female
| 1
| 6
|
Coma
|
Coma
| 0
| null | null | 61
| 33,600.531
| 21,992.5469
| null | 43
|
other
| 22
| 38
| 0.412964
| 0.338989
| 7
| 0
| 0
|
yes
| 0.1
| 0.001
|
dnr after sadm
| 5
| 62
| 2.299805
| 136
| 27
| 37.89844
| 273.3125
| null | null | 1.399902
| 150
| 7.5
| null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 6
| 1
|
61.06198
|
male
| 0
| 14
|
Coma
|
Coma
| 1
| 12
|
>$50k
| 26
| 25,385.047
| 16,424.75
| null | 19
|
white
| 16.5
| 7
| 0.766968
| 0.7229
| 1
| 0
| 0
|
no
| 0.2
| 0.1
|
no dnr
| 14
| 105
| 18.898438
| 74
| 8
| 36.5
| 310
| null | null | 1.099854
| 135
| 7.479492
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,600
| 0
|
24.01399
|
female
| 1
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 37
| 98,734
| 63,452.4688
| null | 38.333313
|
white
| 32.898438
| 41
| 0.711914
| 0.623901
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 17
| 112
| 16.898438
| 144
| 30
| 40
| 110
| null | 0.899902
| 0.699951
| 147
| 7.489258
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 22
| 1
|
54.02899
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$11-$25k
| 0
| 9,305.555
| 6,273.5117
| null | 25
|
white
| 23.898438
| 27
| 0.851929
| 0.756958
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 5
| 53
| 6.899414
| 54
| 11
| 36.09375
| 316
| null | null | 1.199951
| 138
| 7.389648
| null | null | null | 0
| null |
no(M2 and SIP pres)
| 0.4948
| 1,599
| 0
|
45.81497
|
male
| 1
| 3
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| null | null | 100
| 20,466.234
| 13,310
| null | 42
|
white
| 75.796875
| 87
| 0
| 0
| 1
| 0
| 0
|
no
| 0.05
| 0.000125
|
dnr after sadm
| 3
| 0
| 7.199219
| 0
| 22
| 36.39844
| 155.6875
| 1.899902
| null | 4.199219
| 152
| 7.25
| null | null | null | null | null |
<2 mo. follow-up
| 2.129883
| 3
| 1
|
62.65298
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 9,345.742
| 6,544.2227
| null | 14.5
|
white
| 18.097656
| 12
| 0.885986
| 0.809937
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 10
| 87
| 10.798828
| 74
| 26
| 36.19531
| 436
| null | null | 1.099854
| 147
| 7.419922
| null | null | null | 2
| 3
|
no(M2 and SIP pres)
| 3
| 604
| 1
|
48.95599
|
male
| 1
| 69
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 0
| 158,581.125
| 105,985.688
| null | 33.75
|
white
| 26.398438
| 37
| 0.580933
| 0.470947
| 12
| 0
| 0
|
yes
| 0.2
| 0.1
|
dnr after sadm
| 62
| 111
| 6.699219
| 114
| 11
| 36.29688
| 202.84375
| null | null | 6.899414
| 141
| 7.40918
| null | null | null | null | 0
| null | 0
| 69
| 1
|
68.60199
|
female
| 0
| 26
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
|
$11-$25k
| 0
| 32,563.297
| 22,906.7031
| null | 14.75
|
white
| 24.296875
| 57
| 0.685913
| 0.592896
| 1
| 0
| 0
|
yes
| 0.5
| 0.3
|
no dnr
| 26
| 63
| 25.199219
| 126
| 42
| 38.29688
| 194.28125
| 2.599609
| 0.899902
| 1.099854
| 145
| 7.549805
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 244
| 1
|
80.93097
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 21
|
$11-$25k
| 0
| 57,927.031
| 39,838.1875
| null | 30
|
white
| 42.296875
| 62
| 0.194977
| 0.103989
| 1
| 0
| 0
|
yes
| 0.5
| 0.4
|
dnr after sadm
| 16
| 134
| 1
| 126
| 36
| 36
| 160
| 2.399902
| 1.899902
| 3.5
| 142
| 7.489258
| null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
50.95999
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
| null | 9
| 20,149.438
| 13,549.0859
| null | 22
|
white
| 19.597656
| 27
| 0.87793
| 0.835938
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 11
| 59
| 10.199219
| 120
| 6
| 38.09375
| 347.5625
| 2.599609
| 0.199982
| 0.699951
| 143
| 7.449219
| null | null | null | null | 4
|
no(M2 and SIP pres)
| 4
| 1,595
| 0
|
50.64999
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 7,671.547
| 4,854.7148
| null | 12
|
white
| 10.5
| 9
| 0.902954
| 0.776978
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 5
| 117
| 12.699219
| 50
| 20
| 36.39844
| null | 4.199219
| 0.599976
| 1.099854
| 141
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 388
| 1
|
37.396
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
| null | 0
| 27,632.438
| 17,343.8125
| null | 28
|
black
| 19.5
| 27
| 0.915894
| 0.885986
| 1
| 1
| 0
|
no
| 0.3
| 0.28
|
no dnr
| 9
| 61
| 6.899414
| 126
| 10
| 38.39844
| 223.3125
| 2.799805
| 0.599976
| 1.099854
| 153
| 7.479492
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,593
| 0
|
68.02496
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 15
|
>$50k
| 0
| 27,549.688
| 18,694.5938
| null | 19.666656
|
white
| 26.597656
| 42
| 0.754883
| 0.67688
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 16
| 110
| 18.898438
| 104
| 40
| 36.59375
| 146.40625
| null | null | 0.899902
| 139
| 7.369141
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 619
| 1
|
59.86899
|
male
| 0
| 73
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
>$50k
| 0
| 212,689.5
| 137,019
| null | 34.5
|
white
| 29.597656
| 42
| 0.736938
| 0.654907
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 73
| 117
| 14.898438
| 116
| 27
| 39.09375
| 216.65625
| 2.799805
| 6.399414
| 1.299805
| 131
| 7.479492
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,593
| 0
|
74.59796
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 26
| 3,740.498
| 3,070.2441
| null | 14
|
black
| 27.5
| 31
| 0.611938
| 0.42395
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 101
| 8
| 100
| 24
| 35.5
| 356
| null | 6.799805
| 1.699951
| 146
| 7.459961
| null | null | null | null | null | null | 3.637207
| 1,593
| 0
|
69.00494
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 5
|
$11-$25k
| 0
| 20,171.688
| 12,962.7656
| null | 22.5
|
white
| 23.398438
| 47
| 0.807983
| 0.688965
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 9
| 124
| 6.699219
| 176
| 8
| 36.19531
| 233.3125
| null | null | 1.399902
| 137
| 7.389648
| null | null | null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,133
| 1
|
70.89398
|
female
| 1
| 6
|
Coma
|
Coma
| 3
| 11
|
$25-$50k
| 100
| 20,252.891
| 14,738.0078
| null | 32
|
white
| 22.199219
| 36
| 0.198975
| 0.138977
| 1
| 1
| 0
|
no
| null | null |
dnr after sadm
| 5
| 119
| 11.898438
| 100
| 8
| 36.79688
| 386.625
| null | null | 9.898438
| 133
| 7.399414
| null | null | null | null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
64.91998
|
male
| 0
| 32
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
$25-$50k
| 44
| 107,884.5
| 66,731.6875
| null | 34.5
|
white
| 34.695313
| 75
| 0.109985
| 0.046997
| 14
| 0
| 0
|
yes
| null | null |
no dnr
| 32
| 55
| 49.398438
| 210
| 5
| 39.29688
| 253.3125
| 3
| null | 2
| 131
| 7.319336
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 156
| 1
|
67.88495
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 2
| 14
|
$25-$50k
| 0
| 7,538.297
| 5,511.1602
| null | 12
|
white
| 24.296875
| 34
| 0.685913
| 0.392944
| 1
| 0
| 0
|
metastatic
| 0.3
| 0
|
dnr after sadm
| 1
| 77
| 4.299805
| 98
| 20
| 37.19531
| null | null | 19.097656
| 1.099854
| 135
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 16
| 1
|
52.99899
|
male
| 1
| 17
|
Colon Cancer
|
Cancer
| 1
| 10
|
>$50k
| 0
| 24,066.344
| 15,673.8203
| null | 12.333328
|
black
| 21.699219
| 36
| 0.771973
| 0.526978
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 17
| 126
| 4.599609
| 64
| 28
| 38.09375
| null | null | 13
| 1.099854
| 139
| null | null | null | null | 3
| null |
<2 mo. follow-up
| 2.511099
| 17
| 1
|
64.909
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 3,950.5
| 2,913.9922
| null | 6.5
|
white
| 16.199219
| 26
| 0.827881
| 0.625977
| 1
| 1
| 0
|
metastatic
| 0.5
| 0.2
|
no dnr
| 7
| 67
| 5.399414
| 52
| 16
| 37.69531
| null | null | 0.199982
| 1.399902
| 135
| null | null | null | null | 0
| 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
30.795
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 55
| 59,516.188
| 36,226.1875
| null | 42
|
white
| 26.699219
| 33
| 0.720947
| 0.634888
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 13
| 55
| 13.398438
| 116
| 11
| 38.69531
| 148
| 2.5
| 0.5
| 0.899902
| 140
| 7.419922
| null | null | null | null | null |
<2 mo. follow-up
| 2.783691
| 13
| 1
|
38.133
|
female
| 0
| 91
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
|
$11-$25k
| 44
| 202,750.625
| 130,006.375
| null | 24.5
|
white
| 29
| 50
| 0.599976
| 0.492981
| 22
| 0
| 0
|
no
| 0.15
| 0.1
|
no dnr
| 91
| 113
| 27.796875
| 140
| 33
| 38.59375
| 368
| 2.5
| 4.899414
| 1.699951
| 148
| 7.469727
| null | null | null | null | 2
|
SIP>=30
| 2
| 1,587
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.